| Names | |
|---|---|
| IUPAC name 1-Methylpyrrolidine-2,5-dione | |
| Systematic IUPAC name 1-Methyl-2,5-pyrrolidinedione | |
Other names
| |
| Identifiers | |
3D model (JSmol) | |
| 110486 | |
| ChEBI | |
| EC Number |
|
PubChem CID | |
CompTox Dashboard (EPA) | |
| |
| |
| Properties | |
| C5H7NO2 | |
| Molar mass | 113.11 g/mol |
| Appearance | White to off-white crystalline powder |
| Density | 1.127 g/mL |
| Melting point | 66 to 69 (also reported as 68–71 °C and 66–67 °C)66 °C (151 °F; 339 K) |
| Boiling point | 235235 °C (455 °F; 508 K) (also reported as 234–235 °C) |
| Soluble in water | |
| Vapor pressure | 0.0±0.5 mmHg at 25 °C (Predicted) |
| Hazards | |
| Occupational safety and health (OHS/OSH): | |
Main hazards | Irritant |
| GHS labelling: | |
| GHS07 | |
| Warning | |
| H315, H319, H335 | |
| P261, P264, P271, P280, P302+P352, P304+P340, P305+P351+P338, P312, P321, P332+P313, P337+P313, P362, P403+P233, P405, P501 | |
| Flash point | 142.1(Predicted) |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
N-Methylsuccinimide (C5H7NO2, also known as 1-methyl-2,5-pyrrolidinedione or MSI) is an organic compound chemically related to succinimide. It is primarily characterized as a major metabolic product of the industrial solvent N-methyl-2-pyrrolidone (NMP) in mammals, including humans and rats.
One production method involves the reaction of aqueous ammonia and succinate with a methylating agent at temperatures ranging from 100 °C to 400 °C. The resulting N-methylsuccinimide can subsequently be purified and hydrogenated to form NMP. [1] It can also be produced by the reaction of diammonium succinate with methanol or by the reaction of succinic anhydride with methylamine. [2]
In the microelectronics industry, the oxidative degradation of NMP during fabrication processes results in the formation of N-methylsuccinimide. [3] Consequently, it is found in waste NMP mixed liquors. Patents describe methods for purifying waste NMP by removing impurities such as N-methylsuccinimide and gamma-butyrolactone (GBL) using alkali treatment to recover high-purity NMP. [4]
In toxicology and occupational health, N-methylsuccinimide is identified as a metabolite of NMP. Upon exposure to NMP, the compound undergoes a metabolic pathway in which it is first hydroxylated to form 5-hydroxy-N-methyl-2-pyrrolidone (5-HNMP). This intermediate is further oxidized to N-methylsuccinimide (MSI), which is subsequently metabolized to 2-hydroxy-N-methylsuccinimide (2-HMSI). [5]
Experimental studies on male volunteers exposed to NMP vapors indicated that MSI levels in plasma and urine are correlated with exposure concentrations. However, 2-HMSI is often preferred as a biomarker due to its accumulation and delayed excretion profile. In human toxicokinetic studies, the renal clearance of MSI was calculated to be approximately 0.12 L/h, with a total clearance of 8.5 L/h. The apparent volume of distribution for MSI was found to be approximately 120 liters. [5]
While NMP itself is a known reproductive toxicant, research using rat whole embryo culture systems has investigated the embryotoxic potential of its metabolites, including N-methylsuccinimide. [6]
Methods using gas chromatography (GC), sometimes coupled with mass spectrometry (GC-MS), have been used to analyze MSI in plasma and urine samples. [5]
Solid-phase extraction (SPE) combined with gas chromatography and a flame thermionic detector (GC/FTD) has been developed for the determination of NMP and its metabolites, including MSI, in urine. [7]
Studies evaluating biomarkers have employed mass spectrometry to analyze plasma and urine concentrations of MSI and related metabolites. [8]
{{cite journal}}: CS1 maint: article number as page number (link)